An Open Study to Evaluate the Efficacy, Safety and Sustained Effect of Clevudine Monotherapy or Adefovir and Clevudine Combination in Proportion to Roadmap Concept in Patients With Chronic Hepatitis B

NCT01264133 Phase 4 TERMINATED

An open study to Evaluate the Efficacy, Safety and Sustained effect of Clevudine monotherapy or Adefovir and Clevudine combination in proportion to Roadmap concept in Patients with chronic hepatitis B.

Details

Lead sponsor	Bukwang Pharmaceutical
Phase	Phase 4
Status	TERMINATED
Enrolment	200
Start date	2009-09
Completion	2014-12

Conditions

• Chronic Hepatitis B

Interventions

• Clevudine, Adefovir

Primary outcomes

• Proportion of patients with HBV DNA levels < 60 IU/mL — 48 week

Countries

South Korea